Back to Authors

Ellis, Matthew S.

0000-0003-3753-9651

A5044224703 | I204465549

Mayo Clinic

Washington University in St. Louis

Citations 1

Development of Rational Drug Combinations with Investigational Targeted Agents

The Oncologist | May 20, 2010 | Volume: 15 | Issue: 5 | Pages: 496-499

10.1634/theoncologist.2009-0262 | PMID 20489187

This manuscript explores specific examples and criteria in which an alternative regulatory process to the existing combination rule would be appropriate and feasible and thus could be adopted by developers.